| Sequence Name |
Description |
Length |
Blast Hits |
min E-value |
Similarity |
GO hits |
GO names |
Enzyme Codes |
InterPro Scan |
| contig01601 |
---NA--- |
468 |
0 |
|
|
0 |
|
|
|
| contig01602 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
| contig01603 |
platelet-activating factor isoform alpha subunit |
308 |
20 |
6.74E-49 |
77.55% |
39 |
C:nonmotile primary cilium; P:neuron migration; P:retrograde axon cargo transport; P:apical protein localization; P:stem cell division; C:growth cone; P:learning or memory; C:insoluble fraction; P:lipid catabolic process; F:phosphoprotein binding; C:nuclear membrane; P:hippocampus development; P:photoreceptor cell maintenance; C:neuronal cell body; P:neuroblast proliferation; F:hydrolase activity; P:acrosome assembly; C:microtubule; P:layer formation in the cerebral cortex; C:motile primary cilium; P:vesicle transport along microtubule; F:microtubule binding; C:spindle; F:platelet-activating factor acetyltransferase activity; P:mitosis; C:centrosome; P:synaptic transmission; P:microtubule cytoskeleton organization; P:neuromuscular process controlling balance; C:microtubule associated complex; P:actin cytoskeleton organization; C:perinuclear region of cytoplasm; F:protein homodimerization activity; C:vesicular fraction; C:soluble fraction; C:cell leading edge; P:regulation of Rho GTPase activity; F:dynein intermediate chain binding; P:adult locomotory behavior |
EC:2.3.1.149 |
|
| contig01604 |
snail homolog 1 |
1028 |
20 |
1.27E-49 |
93.80% |
11 |
P:mesodermal cell migration; P:hair follicle morphogenesis; F:zinc ion binding; P:epithelial to mesenchymal transition; P:zinc ion transport; P:regulation of transcription, DNA-dependent; F:protein binding; F:transcription factor activity; P:negative regulation of cell cycle; P:negative regulation of cell-cell adhesion; C:nucleus |
|
|
| contig01605 |
---NA--- |
522 |
0 |
|
|
0 |
|
|
|
| contig01606 |
---NA--- |
331 |
0 |
|
|
0 |
|
|
|
| contig01607 |
casein kinase alpha 1 polypeptide |
566 |
20 |
8.97E-105 |
96.15% |
12 |
C:protein kinase CK2 complex; F:protein N-terminus binding; P:Wnt receptor signaling pathway; F:beta-catenin binding; F:protein phosphatase regulator activity; P:regulation of cell growth; F:protein kinase CK2 activity; F:ATP binding; P:regulation of cell proliferation; C:nucleus; C:plasma membrane; P:protein amino acid phosphorylation |
|
|
| contig01608 |
---NA--- |
398 |
0 |
|
|
0 |
|
|
|
| contig01609 |
---NA--- |
373 |
0 |
|
|
0 |
|
|
|
| contig01610 |
myst histone acetyltransferase 1 |
766 |
20 |
4.43E-114 |
98.20% |
13 |
F:zinc ion binding; P:regulation of transcription, DNA-dependent; P:chromatin assembly or disassembly; P:myeloid cell differentiation; C:kinetochore; C:chromatin; F:transcription factor binding; P:negative regulation of transcription; F:histone acetyltransferase activity; P:histone acetylation; F:chromatin binding; C:nucleus; P:positive regulation of transcription |
EC:2.3.1.48 |
|
| contig01611 |
hydrolethalus syndrome 1 |
386 |
20 |
2.39E-40 |
72.25% |
1 |
C:nucleus |
|
|
| contig01612 |
rna binding motif protein 26 |
280 |
20 |
4.33E-34 |
80.30% |
3 |
F:zinc ion binding; F:nucleotide binding; F:RNA binding |
|
|
| contig01613 |
---NA--- |
350 |
0 |
|
|
0 |
|
|
|
| contig01614 |
eukaryotic translation initiation factor subunit 2 38kda |
371 |
20 |
1.39E-11 |
100.00% |
2 |
P:translational initiation; F:translation initiation factor activity |
|
|
| contig01615 |
coiled-coil-helix-coiled-coil-helix domain containing 3 |
1168 |
20 |
2.40E-34 |
71.70% |
2 |
C:mitochondrial inner membrane; F:protein binding |
|
|
| contig01616 |
---NA--- |
454 |
0 |
|
|
0 |
|
|
|
| contig01617 |
transient receptor potential cation subfamily member 4 associated protein |
538 |
20 |
6.32E-73 |
87.95% |
17 |
C:cytosol; F:peptide antigen binding; F:tapasin binding; P:cytosol to ER transport; F:peptide antigen-transporting ATPase activity; P:antigen processing and presentation of endogenous peptide antigen via MHC class I; F:MHC class I protein binding; F:TAP2 binding; P:protein complex assembly; P:peptide transport; F:ATP binding; C:endoplasmic reticulum lumen; F:phosphate binding; F:protein heterodimerization activity; F:protein homodimerization activity; P:intracellular protein transport; F:TAP1 binding |
|
|
| contig01618 |
prp31 pre-mrna processing factor 31 homolog |
1050 |
20 |
1.51E-146 |
96.40% |
7 |
F:ribonucleoprotein binding; ; C:Cajal body; C:U4/U6 x U5 tri-snRNP complex; C:spliceosomal complex; F:protein binding; C:nuclear speck |
|
|
| contig01619 |
glycine cleavage system h mitochondrial precursor |
995 |
20 |
4.00E-77 |
81.85% |
5 |
P:glycine catabolic process; F:aminomethyltransferase activity; F:lipoic acid binding; C:glycine cleavage complex; C:mitochondrion |
EC:2.1.2.10 |
|
| contig01620 |
imp1 inner mitochondrial membrane peptidase-like |
640 |
20 |
1.17E-81 |
80.10% |
5 |
C:mitochondrial inner membrane; C:integral to membrane; F:serine-type peptidase activity; P:proteolysis; F:signal peptidase activity |
|
|
| contig01621 |
---NA--- |
744 |
0 |
|
|
0 |
|
|
|
| contig01622 |
---NA--- |
419 |
0 |
|
|
0 |
|
|
|
| contig01623 |
novel protein (zgc:66455) |
1668 |
16 |
3.39E-62 |
59.63% |
0 |
|
|
|
| contig01624 |
---NA--- |
947 |
0 |
|
|
0 |
|
|
|
| contig01625 |
splicing arginine serine-rich 1 |
266 |
20 |
1.73E-30 |
97.50% |
10 |
C:nuclear speck; P:mRNA splice site selection; P:protein targeting; F:protein binding; C:spliceosomal complex; F:nucleotide binding; ; C:cytoplasm; P:in utero embryonic development; P:cardiac muscle contraction |
|
|
| contig01626 |
---NA--- |
486 |
0 |
|
|
0 |
|
|
|
| contig01627 |
coenzyme q10 homolog b |
377 |
20 |
3.16E-32 |
64.45% |
1 |
C:mitochondrion |
|
|
| contig01628 |
spna2 protein |
342 |
20 |
1.59E-15 |
100.00% |
0 |
|
|
|
| contig01629 |
ubiquitin a-52 residue ribosomal protein fusion product 1 |
508 |
20 |
3.01E-36 |
99.40% |
5 |
C:ribosome; P:protein modification process; F:structural constituent of ribosome; C:nucleus; P:translation |
EC:3.6.5.3 |
|
| contig01630 |
basic leucine zipper and w2 domains 1 |
753 |
20 |
1.64E-119 |
91.60% |
5 |
C:cytoplasm; P:regulation of translational initiation; P:transcription antitermination; F:translation initiation factor activity; P:regulation of transcription, DNA-dependent |
|
|
| contig01631 |
---NA--- |
462 |
0 |
|
|
0 |
|
|
|
| contig01632 |
lsm14 homolog b |
1655 |
20 |
6.11E-135 |
66.95% |
2 |
F:F; C:C |
|
|
| contig01633 |
shugoshin-like 1 |
800 |
4 |
8.38E-10 |
50.00% |
0 |
|
|
|
| contig01634 |
arachidonate 12- 12r type |
1192 |
20 |
1.85E-67 |
62.60% |
4 |
P:lipid metabolic process; C:intracellular; P:negative regulation of cellular process; F:oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen |
EC:1.13.11.0 |
|
| contig01635 |
---NA--- |
258 |
0 |
|
|
0 |
|
|
|
| contig01636 |
chromosome 14 open reading frame 153 |
581 |
20 |
1.36E-61 |
71.20% |
1 |
P:induction of apoptosis by intracellular signals |
|
|
| contig01637 |
spry domain containing 4 |
398 |
20 |
6.50E-53 |
77.70% |
2 |
F:F; C:C |
|
|
| contig01638 |
---NA--- |
949 |
0 |
|
|
0 |
|
|
|
| contig01639 |
---NA--- |
260 |
0 |
|
|
0 |
|
|
|
| contig01640 |
molybdenum cofactor synthesis 2 |
860 |
20 |
4.87E-70 |
71.05% |
2 |
F:identical protein binding; P:Mo-molybdopterin cofactor biosynthetic process |
|
|
| contig01641 |
tho complex 5 |
2292 |
20 |
0 |
81.95% |
4 |
C:cytoplasm; F:protein binding; C:nucleus; P:negative regulation of macrophage differentiation |
|
|
| contig01642 |
---NA--- |
739 |
0 |
|
|
0 |
|
|
|
| contig01643 |
---NA--- |
362 |
0 |
|
|
0 |
|
|
|
| contig01644 |
dead h (asp-glu-ala-asp his) box polypeptide 19 (dbp5 yeast) |
561 |
20 |
5.65E-70 |
93.30% |
3 |
F:nucleic acid binding; F:ATP binding; F:ATP-dependent helicase activity |
|
|
| contig01645 |
---NA--- |
332 |
0 |
|
|
0 |
|
|
|
| contig01646 |
vaccinia related kinase 1 |
318 |
20 |
1.42E-48 |
86.60% |
4 |
F:ATP binding; C:nucleus; P:protein amino acid autophosphorylation; F:protein serine/threonine kinase activity |
EC:2.7.11.0 |
|
| contig01647 |
---NA--- |
507 |
0 |
|
|
0 |
|
|
|
| contig01648 |
mitochondrial isoleucine trna synthetase |
275 |
20 |
2.84E-09 |
88.45% |
4 |
C:mitochondrial matrix; P:isoleucyl-tRNA aminoacylation; F:ATP binding; F:isoleucine-tRNA ligase activity |
EC:6.1.1.5 |
|
| contig01649 |
---NA--- |
155 |
0 |
|
|
0 |
|
|
|
| contig01650 |
family with sequence similarity member a |
441 |
20 |
2.07E-23 |
84.55% |
2 |
F:F; P:P |
|
|
| contig01651 |
spindle pole body component 24 homolog |
314 |
19 |
6.04E-20 |
74.42% |
4 |
C:chromosome, centromeric region; P:mitosis; C:nucleus; F:protein binding |
|
|
| contig01652 |
mitochondrial ribosomal protein s31 |
569 |
5 |
4.86E-16 |
61.60% |
0 |
|
|
|
| contig01653 |
---NA--- |
365 |
0 |
|
|
0 |
|
|
|
| contig01654 |
stomatin-like protein 2 |
781 |
13 |
6.42E-07 |
72.54% |
3 |
F:F; C:membrane; P:P |
|
|
| contig01655 |
---NA--- |
469 |
0 |
|
|
0 |
|
|
|
| contig01656 |
sec23 interacting protein |
260 |
20 |
1.87E-16 |
85.50% |
1 |
F:metal ion binding |
|
|
| contig01657 |
nucleolar protein 27kda |
742 |
18 |
1.01E-19 |
63.33% |
1 |
C:nucleus |
|
|
| contig01658 |
rna binding homolog 1 |
244 |
20 |
1.83E-32 |
83.05% |
3 |
P:germ cell development; C:intracellular; F:double-stranded RNA binding |
|
|
| contig01659 |
breast carcinoma amplified sequence 2 |
1542 |
20 |
3.63E-108 |
91.45% |
4 |
C:spliceosomal complex; ; P:RNA splicing; F:protein binding |
|
|
| contig01660 |
dead (asp-glu-ala-asp) box polypeptide 52 |
1185 |
20 |
5.31E-130 |
89.00% |
6 |
F:RNA helicase activity; F:ATP-dependent helicase activity; F:RNA binding; F:ATP binding; P:rRNA processing; C:nucleus |
|
|
| contig01661 |
---NA--- |
248 |
0 |
|
|
0 |
|
|
|
| contig01662 |
wu:fa99c08 protein |
374 |
4 |
1.48E-13 |
79.25% |
0 |
|
|
|
| contig01663 |
biogenesis of lysosome-related organelles complex- subunit 2 |
1405 |
20 |
1.44E-51 |
89.25% |
3 |
C:cytosol; C:centrosome; F:identical protein binding |
|
|
| contig01664 |
glutamine synthetase |
794 |
20 |
8.97E-113 |
95.30% |
3 |
F:glutamate-ammonia ligase activity; C:mitochondrion; P:glutamine biosynthetic process |
EC:6.3.1.2 |
|
| contig01665 |
---NA--- |
277 |
0 |
|
|
0 |
|
|
|
| contig01666 |
---NA--- |
221 |
0 |
|
|
0 |
|
|
|
| contig01667 |
tetratricopeptide repeat domain 35 |
290 |
20 |
9.62E-13 |
92.80% |
3 |
C:nucleus; F:binding; C:endoplasmic reticulum |
|
|
| contig01668 |
cadherin epithelial |
1737 |
20 |
0 |
59.90% |
26 |
P:neuron migration; P:transport; P:neural tube formation; P:ectoderm development; P:germ cell migration; C:catenin complex; P:neuron projection development; P:response to organic substance; C:cell-cell adherens junction; P:cell migration involved in gastrulation; P:cell-cell adhesion; C:basolateral plasma membrane; C:microvillus; P:pituitary gland development; F:calcium ion binding; P:gastrulation with mouth forming second; C:integral to membrane; C:desmosome; P:response to drug; C:apical part of cell; P:response to toxin; P:protein homooligomerization; F:beta-catenin binding; P:synapse assembly; P:regulation of caspase activity; C:cell cortex |
|
|
| contig01669 |
---NA--- |
285 |
0 |
|
|
0 |
|
|
|
| contig01670 |
dolichyl-diphosphooligosaccharide-protein glycosyltransferase |
270 |
20 |
3.25E-21 |
86.20% |
10 |
P:protein amino acid N-linked glycosylation via asparagine; C:integral to membrane; C:extracellular space; C:microsome; F:protein binding; P:response to cytokine stimulus; P:T cell activation; P:protein amino acid terminal N-glycosylation; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; C:endoplasmic reticulum membrane |
EC:2.4.1.119 |
|
| contig01671 |
coiled-coil domain containing 93 |
453 |
20 |
6.68E-59 |
97.80% |
2 |
F:F; C:C |
|
|
| contig01672 |
beta |
253 |
20 |
1.94E-29 |
70.50% |
5 |
C:extracellular space; F:beta-lactamase activity; C:integral to membrane; P:beta-lactam antibiotic catabolic process; C:mitochondrion |
EC:3.5.2.6 |
|
| contig01673 |
---NA--- |
471 |
0 |
|
|
0 |
|
|
|
| contig01674 |
novel protein |
615 |
20 |
1.60E-37 |
63.40% |
0 |
|
|
|
| contig01675 |
---NA--- |
125 |
0 |
|
|
0 |
|
|
|
| contig01676 |
---NA--- |
252 |
0 |
|
|
0 |
|
|
|
| contig01677 |
---NA--- |
551 |
0 |
|
|
0 |
|
|
|
| contig01678 |
c1orf74 homolog |
743 |
20 |
3.43E-68 |
58.05% |
4 |
F:F; P:transcription; C:nucleus; C:C |
|
|
| contig01679 |
---NA--- |
254 |
0 |
|
|
0 |
|
|
|
| contig01680 |
nadh dehydrogenase iron-sulfur protein mitochondrial precursor |
784 |
20 |
1.71E-100 |
85.45% |
9 |
P:transport; F:NADH dehydrogenase (ubiquinone) activity; C:mitochondrial respiratory chain complex I; F:4 iron, 4 sulfur cluster binding; P:mitochondrial electron transport, NADH to ubiquinone; F:protein binding; P:mitochondrial respiratory chain complex I assembly; F:iron ion binding; P:electron transport |
EC:1.6.5.3 |
|
| contig01681 |
mitochondrial ribosomal protein s28 |
729 |
20 |
1.20E-41 |
65.10% |
1 |
C:mitochondrial small ribosomal subunit |
|
|
| contig01682 |
---NA--- |
276 |
0 |
|
|
0 |
|
|
|
| contig01683 |
dna replication complex gins protein psf2 |
557 |
20 |
3.03E-28 |
86.00% |
4 |
F:transcription elongation regulator activity; C:nucleus; P:DNA strand elongation involved in DNA replication; F:protein binding |
|
|
| contig01684 |
heat shock protein 9 |
458 |
20 |
2.29E-59 |
99.05% |
9 |
P:protein folding; P:hemopoiesis; P:protein export from nucleus; C:cell surface; F:ATP binding; F:ATPase activity; C:mitochondrial matrix; F:unfolded protein binding; P:response to stress |
|
|
| contig01685 |
programmed cell death 4 |
542 |
20 |
9.11E-27 |
83.15% |
6 |
P:apoptosis; F:RNA binding; C:cytoplasm; P:negative regulation of cell cycle; C:nucleus; F:protein binding |
|
|
| contig01686 |
ras-like family 11 member b |
1700 |
20 |
1.25E-104 |
75.70% |
2 |
F:GTP binding; P:small GTPase mediated signal transduction |
|
|
| contig01687 |
xbp1 protein |
600 |
4 |
1.82E-06 |
92.50% |
6 |
P:regulation of transcription, DNA-dependent; F:sequence-specific DNA binding; F:protein dimerization activity; F:transcription regulator activity; F:transcription factor activity; F:DNA binding |
|
|
| contig01688 |
---NA--- |
739 |
0 |
|
|
0 |
|
|
|
| contig01689 |
isoform cra_a |
862 |
20 |
4.70E-97 |
92.60% |
1 |
F:protein binding |
|
|
| contig01690 |
lim domain binding 1 |
252 |
20 |
3.64E-44 |
100.00% |
11 |
P:anterior/posterior axis specification; P:negative regulation of erythrocyte differentiation; P:Wnt receptor signaling pathway; F:transcription cofactor activity; C:protein complex; P:positive regulation of transcription from RNA polymerase II promoter; F:LIM domain binding; F:transcription activator activity; F:protein homodimerization activity; P:neuron differentiation; C:nucleus |
|
|
| contig01691 |
---NA--- |
486 |
0 |
|
|
0 |
|
|
|
| contig01692 |
---NA--- |
271 |
0 |
|
|
0 |
|
|
|
| contig01693 |
---NA--- |
147 |
0 |
|
|
0 |
|
|
|
| contig01694 |
wolf-hirschhorn syndrome candidate 2 |
751 |
20 |
5.64E-58 |
95.10% |
3 |
P:multicellular organismal development; C:nucleus; P:regulation of transcription, DNA-dependent |
|
|
| contig01695 |
---NA--- |
631 |
0 |
|
|
0 |
|
|
|
| contig01696 |
valyl-trna synthetase |
395 |
20 |
1.28E-65 |
79.10% |
6 |
C:cytoplasm; P:valyl-tRNA aminoacylation; F:protein binding; F:ATP binding; F:valine-tRNA ligase activity; P:translational elongation |
EC:6.1.1.9 |
|
| contig01697 |
---NA--- |
460 |
0 |
|
|
0 |
|
|
|
| contig01698 |
serologically defined colon cancer antigen 10 |
149 |
20 |
9.37E-08 |
82.35% |
1 |
F:peptidyl-prolyl cis-trans isomerase activity |
EC:5.2.1.8 |
|
| contig01699 |
serologically defined colon cancer antigen 10 |
141 |
20 |
3.11E-16 |
90.40% |
4 |
P:protein folding; C:cytoplasm; F:peptidyl-prolyl cis-trans isomerase activity; C:nucleus |
EC:5.2.1.8 |
|
| contig01700 |
---NA--- |
361 |
0 |
|
|
0 |
|
|
|
100 Rows returned.
Helpdesk 